Dopamine- and tyramine-based derivatives of triazenes: Activation by tyrosinase and implications for prodrug design

European Journal of Medicinal Chemistry
2009.0

Abstract

A range of triazene derivatives were synthesized and investigated as prodrug candidates for melanocyte-directed enzyme prodrug therapy (MDEPT). The prodrugs contained a tyramine or dopamine promoiety required for tyrosinase activation and this was joined via a urea functional group to the cytotoxic triazene. The stability of each of the prodrugs in phosphate buffer, human plasma and in mushroom tyrosinase is discussed. The identification of the main peak formed after the tyrosinase reaction was attempted by LC-MS and the conversion of prodrug to the quinone was confirmed.

Knowledge Graph

Similar Paper

Dopamine- and tyramine-based derivatives of triazenes: Activation by tyrosinase and implications for prodrug design
European Journal of Medicinal Chemistry 2009.0
Synthesis and evaluation of N-acylamino acids derivatives of triazenes. Activation by tyrosinase in human melanoma cell lines
European Journal of Medicinal Chemistry 2013.0
The selective cytotoxicity of new triazene compounds to human melanoma cells
Bioorganic & Medicinal Chemistry 2017.0
Synthesis and analysis of activity of a potential anti-melanoma prodrug with a hydrazine linker
European Journal of Medicinal Chemistry 2014.0
Synthesis and structure–activity relationships of phenylpropanoid amides of serotonin on tyrosinase inhibition
Bioorganic & Medicinal Chemistry Letters 2011.0
Analogues of N-hydroxycinnamoylphenalkylamides as inhibitors of human melanocyte-tyrosinase
Bioorganic & Medicinal Chemistry Letters 2006.0
Sulfur Analogues of Tyrosine in the Development of Triazene Hybrid Compounds: A New Strategy against Melanoma
ACS Medicinal Chemistry Letters 2021.0
Synthesis of pyrazolo[4,3-e][1,2,4]triazine sulfonamides, novel Sildenafil analogs with tyrosinase inhibitory activity
Bioorganic & Medicinal Chemistry 2014.0
Design, synthesis and biological evaluation of tyrosinase-targeting PROTACs
European Journal of Medicinal Chemistry 2021.0
N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells
Bioorganic & Medicinal Chemistry Letters 2009.0